National Institute Of Kidney Disease And Urology (nikdu)

This study looked at whether atorvastatin, a cholesterol-lowering drug, is safe and effective for children aged 8-18 with steroid-sensitive nephrotic syndrome who also have high cholesterol. The goal was to see how many children reached healthy cholesterol levels within 3 to 6 mo…